Shigellosis: Epidemiology in India

Indian Journal of Medical Research

Volumn 143, Issue MAY, 2016, Pages 565-576

  Taneja, Neelam ^a   Mewara, Abhishek ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Epidemiology; India; MDR Shigella; Molecular epidemiology; Shigellosis

Indexed keywords

AMIKACIN; AMPICILLIN; AZITHROMYCIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; PIVMECILLINAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SHIGA TOXIN; SHIGELLA VACCINE; SULFONAMIDE; TETRACYCLINE; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLINICAL TRIAL (TOPIC); DEHYDRATION; DIARRHEA; DISEASE CARRIER; DISEASE CONTROL; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALNUTRITION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR GENETICS; MORTALITY; MULTICENTER STUDY (TOPIC); MULTIDRUG RESISTANCE; ORAL REHYDRATION THERAPY; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SANITATION; SEROPREVALENCE; SEXUAL TRANSMISSION; SHIGELLA; SHIGELLOSIS; DYSENTERY, BACILLARY; EPIDEMIC; INDIA; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY; SHIGELLA FLEXNERI;

ANTI-BACTERIAL AGENTS; DIARRHEA; DISEASE OUTBREAKS; DYSENTERY, BACILLARY; FLUOROQUINOLONES; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; SHIGELLA FLEXNERI;

EID: 84979652093     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: 10.4103/0971-5916.187104     Document Type: Review

References (102)

1. DuPont HL. Shigella species (bacillary dysentery). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone Elsevier; 2010. p. 2905-10
2. von Seidlein L, Kim DR, Ali M, Hyejon Lee H, Wang X, Thiem VD, et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med 2006; 3: e353
3. Kuo CY, Su LH, Perera J, Carlos C, Tan BH, Kumarasinghe G, et al. Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001-2004. J Microbiol Immunol Infect 2008; 41: 107-11
4. Taneja N, Mewara A, Kumar A, Verma G, Sharma M. Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India. J Antimicrob Chemother 2012; 67: 1347-53
5. Li YL, Tewari D, Yealy CC, Fardig D, M’ikanatha NM. Surveillance for travel and domestically acquired multidrug-resistant human shigella infections-Pennsylvania, 2006-2014. Health Secur 2016; 14: 143-51
6. Nüesch-Inderbinen M, Heini N, Zurfluh K, Althaus D, Hächler H, Stephan R. Shigella antimicrobial drug resistance mechanisms, 2004-2014. Emerg Infect Dis 2016; 22: 1083-5
7. Shiga K. About the causative agent of dysentery in Japan: Preliminary communication. Zentralbal Bakteriol Microbiol Hyg 1898; 23: 599-600
8. Flexner S. On the etiology of tropical dysentery. Bull Johns Hopkins Hosp 1900; 11: 231-42
9. Kruse W. About the dysentry as a widespread disease and its pathogens. Dtsch Med Wochenschr 1900; 26: 637-9
10. Venkatesan M, Fernandez-Prada C, Buysse JM, Formal SB, Hale TL. Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain. Vaccine 1991; 9: 358-63
11. Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, et al. Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun 2003; 71: 2775-86
12. Venkatesan MM, Ranallo RT. Live-attenuated Shigella vaccines. Expert Rev Vaccines 2006; 5: 669-86
13. Taneja N, Khurana S, Verma AD, Sharma M. Changing trends in shigellosis at a tertiary care centre. Indian J Pathol Microbiol 2003; 46: 280-1
14. Taneja N, Lyngdoh V, Vermani A, Mohan B, Rao P, Singh M, et al. Re-emergence of multi-drug resistant Shigella dysenteriae with added resistance to ciprofloxacin in north India & their plasmid profiles. Indian J Med Res 2005; 122: 348-54
15. Taneja N, Lyngdoh VW, Sharma M. Haemolytic uraemic syndrome due to ciprofloxacin-resistant Shigella dysenteriae serotype 1. J Med Microbiol 2005; 54: 997-8
16. Taneja N. Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant Shigellae in India. J Clin Microbiol 2007; 45: 678-9
17. Pazhani GP, Ramamurthy T, Mitra U, Bhattacharya SK, Niyogi SK. Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiol Infect 2005; 133: 1089-95
18. Mamatha B, Rituparna C. Decreased susceptibility to antimicrobials among Shigella flexneri isolates in Manipal, South India - a 5 year hospital based study. Southeast Asian J Trop Med Public Health 2012; 43: 1447-51
19. Mandal JVG, Emelda JSM, Parija SC. The recent trends of Shigellosis: A JIPMER perspective. J Clin Diagn Res 2012; 6: 1474-7
20. Nair GB, Ramamurthy T, Bhattacharya MK, Krishnan T, Ganguly S, Saha DR, et al. Emerging trends in the etiology of enteric pathogens as evidenced from an active surveillance of hospitalized diarrhoeal patients in Kolkata, India. Gut Pathog 2010; 2: 4.
21. Livio S, Strockbine NA, Panchalingam S, Tennant SM, Barry EM, Marohn ME, et al. Shigella isolates from the Global Enteric Multicenter Study Inform Vaccine Development. Clin Infect Dis 2014; 59: 933-41
22. Bhattacharya D, Bhattacharya H, Thamizhmani R, Sayi DS, Reesu R, Anwesh M, et al. Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011. Eur J Clin Microbiol Infect Dis 2014; 33: 157-70
23. Niyogi SK. Shigellosis. J Microbiol 2005; 43: 133-43
24. Sharma A, Singh SK, Bajpai D. Phenotypic and genotypic characterization of Shigella spp. with reference to its virulence genes and antibiogram analysis from river Narmada. Indian J Microbiol 2009; 49: 259-65
25. Faruque SM, Khan R, Kamruzzaman M, Yamasaki S, Ahmad QS, Azim T, et al. Isolation of Shigella dysenteriae type 1 and S. flexneri strains from surface waters in Bangladesh: comparative molecular analysis of environmental Shigella isolates versus clinical strains. Appl Environ Microbiol 2002; 68: 3908-13
26. Murugesan P, Revathi K, Elayaraja S, Vijayalakshmi S, Balasubramanian T. Distribution of enteric bacteria in the sediments of Parangipettai and Cuddalore coast of India. J Environ Biol 2012; 33: 705-11
27. Saeed A, Abd H, Edvinsson B, Sandström G. Acanthamoeba castellanii an environmental host for Shigella dysenteriae and Shigella sonnei. Arch Microbiol 2009; 191: 83-8
28. Gupta AK, Nayduch D, Verma P, Shah B, Ghate HV, Patole MS, et al. Phylogenetic characterization of bacteria in the gut of house flies (Musca domestica L.). FEMS Microbiol Ecol 2012; 79: 581-93
29. Vicens R, Richard C, Coulanges P, Rasoamamunjy MA. A reservoir of Shigella of avian origin: herons and birds of prey of the zoological garden in Tananarive. Bull Soc Pathol Exot Filiales 1987; 80: 295-300
30. Kalai K, Nehete RS, Ganguly S, Ganguli M, Dhanalakshmi S, Mukhopadhayay SK. Investigation of parasitic and bacterial diseases in pigs with analysis of hematological and serum biochemical profile. J Parasit Dis 2012; 36: 129-34
31. Bachand N, Ravel A, Onanga R, Arsenault J, Gonzalez JP. Public health significance of zoonotic bacterial pathogens from bushmeat sold in urban markets of Gabon, Central Africa. J Wildl Dis 2012; 48: 785-9
32. Torres AG. Current aspects of Shigella pathogenesis. Rev Latinoam Microbiol 2004; 46: 89-97
33. Dorman CJ, Porter ME. The Shigella virulence gene regulatory cascade: a paradigm of bacterial gene control mechanisms. Mol Microbiol 1998; 29: 677-84
34. Thapa BR, Ventkateswarlu K, Malik AK, Panigrahi D. Shigellosis in children from north India: a clinicopathological study. J Trop Pediatr 1995; 41: 303-7
35. Das M, Rath CC, Mohapatra UB. Bacteriology of a most popular street food (Panipuri) and inhibitory effect of essential oils on bacterial growth. J Food Sci Technol 2012; 49: 564-71
36. Khurana S, Taneja N, Thapar R, Sharma M, Malla N. Intestinal bacterial and parasitic infections among food handlers in a tertiary care hospital of North India. Trop Gastroenterol 2008; 29: 207-9
37. Iwamoto M, Ayers T, Mahon BE, Swerdlow DL. Epidemiology of seafood-associated infections in the United States. Clin Microbiol Rev 2010; 23: 399-411
38. Weissman JB, Gangorosa EJ, Schmerler A, Marier RL, Lewis JN. Shigellosis in day-care centres. Lancet 1975; 1: 88-90
39. DuPont HL, Gangarosa EJ, Reller LB, Woodward WE, Armstrong RW, Hammond J, et al. Shigellosis in custodial institutions. Am J Epidemiol 1970; 92: 172-9
40. Wanyiri JW, Kanyi H, Maina S, Wang DE, Ngugi P, O’Connor R, et al. Infectious diarrhoea in antiretroviral therapy-naive HIV/AIDS patients in Kenya. Trans R Soc Trop Med Hyg 2013; 107: 631-8
41. Dritz SK, Back AF. Shigella enteritis venereally transmitted. N Engl J Med 1974; 291: 1194
42. Tauxe RV, McDonald RC, Hargrett-Bean N, Blake PA. The persistence of Shigella flexneri in the United States: increasing role of adult males. Am J Public Health 1988; 78: 1432-5
43. Baer JT, Vugia DJ, Arthur L, Aragon T, Angulo FJ, Bradford WZ. HIV infection as a risk factor for Shigellosis. Emerg Infect Dis1999; 5: 820-3
44. Aragon TJ, Vugia DJ, Shallow S, Samuel MC, Reingold A, Angulo FJ, et al. Case-control study of Shigellosis in San Francisco: The role of sexual transmission and HIV infection. Clin Infect Dis 2007; 44: 327-34
45. Strauss B, Kurzac C, Embree G, Sevigny R, Paccagnella A, Fyfe M. Clusters of Shigella sonnei in men who have sex with men, British Columbia, 2001. Can Commun Dis Rep 2001; 27: 109-14
46. O’Sullivan B, Delpech V, Pontivivo G, Karagiannis T, Marriott D, Harkness J, et al. Shigellosis linked to sex venues, Australia. Emerg Infect Dis 2002; 8: 862-4
47. Centers for Disease Control and Prevention. Shigella flexneri serotype 3 infections among men who have sex with men-Chicago, Illinois, 2003-2004. MMWR Morb Mortal Wkly Rep 2005; 54: 820-2
48. Morgan O, Crook P, Cheasty T, Jiggle B, Giraudon I, Hughes H, et al. Shigella sonnei outbreak among homosexual men, London. Emerg Infect Dis 2006; 12: 1458-60
49. Kulkarni S, Patsute S, Sane S, Chandane M, Vidhate P, Risbud A. Enteric pathogens in HIV infected and HIV uninfected individuals with diarrhea in Pune. Trans R Soc Trop Med Hyg 2013; 107: 648-52
50. Uppal B, Kashyap B, Bhalla P. Enteric pathogens in HIV/AIDS from a tertiary care hospital. Indian J Community Med 2009; 34: 237-42
51. Gassama A, Thiaw B, Dia NM, Fall F, Camara P, Hovette P, et al. Infective etiology of diarrhea in adults with HIV infection in Dakar: a case-control study on 594 patients. Dakar Med 2001; 46: 46-50
52. Kristjansson M, Viner B, Maslow JN. Polymicrobial and recurrent bacteremia with Shigella in a patient with AIDS. Scand J Infect Dis 1994; 26: 411-6
53. Freeman N, Newman H, Abrahams R. Shigella keratitis in an HIV-exposed infant. Pediatr Infect Dis J 2013; 32: 426-7
54. Miller RF, Symeonidou C, Shaw PJ. Pneumonia complicating Shigella sonnei dysentery in an HIV-infected adult male. Int J STD AIDS 2005; 16: 763-5
55. Sur D, Ramamurthy T, Deen J, Bhattacharya SK. Shigellosis: challenges & management issues. Indian J Med Res 2004; 120: 454-62
56. Mandell W, Neu H. Shigella bacteremia in adults. JAMA 1986; 255: 3116-7
57. Raffensperger EC. Combined bacillary and amebic ulcerative colitis associated with atypical pneumonitis and Shigella-positive sputum. Am J Med 1956; 20: 964-7
58. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999; 77: 651-66
59. Das SK, Rahman A, Chisti MJ, Ahmed S, Malek MA, Salam MA, et al. Changing patient population in Dhaka Hospital and Matlab Hospital of ICDDR, B. Trop Med Int Health 2014; 19: 240-3
60. Nandy S, Mitra U, Rajendran K, Dutta P, Dutta S. Subtype prevalence, plasmid profiles and growing fluoroquinolone resistance in Shigella from Kolkata, India (2001-2007): a hospital-based study. Trop Med Int Health 2010; 15: 1499-507
61. Rahaman MM, Khan MM, Aziz KM, Islam MS, Kibriya AK. An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal. J Infect Dis 1975; 132: 15-9
62. Sheriff MHR. Lessons to learn from my Maldivian experience with the Shigella dysentery. Sri Lankan Family Physician 1982; 5: 117-20
63. Pal SC, Sengupta PG, Sen D, Bhattacharya SK, Deb BC. Epidemic shigellosis due to Shigella dysenteriae type 1 in south Asia. Indian J Med Res 1989; 89: 57-64
64. Naheed A, Kalluri P, Talukder KA, Faruque AS, Khatun F, Nair GB, et al. Fluoroquinolone-resistant Shigella dysenteriae type 1 in northeastern Bangladesh. Lancet Infect Dis 2004; 4: 607-8
65. Mathan VI, Bhat P, Kapadia CR, Ponniah J, Baker SJ. Epidemic dysentery caused by the Shiga bacillus in a southern Indian village. J Diarrhoeal Dis Res 1984; 2: 27-32
66. Jesudason MV. Shigella isolation in Vellore, south India (1997-2001). Indian J Med Res 2002; 115: 11-3
67. Pal SC. Epidemic bacillary dysentery in West Bengal, India, 1984. Lancet 1984; 1: 1462
68. Dutta P, Bhattacharya SK, Dutta D, Sen D, Saha MR, Nair GB, et al. Clinical presentation of shigellosis during the 1984 epidemic of bacillary dysentery in West Bengal. J Assoc Physicians India 1987; 35: 195-7
69. Sen D, Sengupta PG, Bhattacharya SK, Sinha AK, Pal SC, Lall R. Epidemic Shiga bacillus dysentery in Port Blair, Andaman and Nicobar Islands, India. J Diarrhoeal Dis Res 1986; 4: 161-2
70. Bhattacharya SK, Sinha AK, Sen D, Sengupta PG, Lall R, Pal SC. Extraintestinal manifestations of Shigellosis during an epidemic of bacillary dysentery in Port Blair, Andaman & Nicobar Island (India). J Assoc Physicians India 1988; 36: 319-20
71. Sarkar K, Ghosh S, Niyogi SK, Bhattacharya SK. Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones. Lancet 2003; 361: 785
72. Saha T, Murhekar M, Hutin YJ, Ramamurthy T. An urban, water-borne outbreak of diarrhoea and shigellosis in a district town in eastern India. Natl Med J India 2009; 22: 237-9
73. Nandy S, Dutta S, Ghosh S, Ganai A, Rajahamsan J, Theodore RB, et al. Foodborne-associated Shigella sonnei, India, 2009 and 2010. Emerg Infect Dis 2011; 17: 2072-4
74. Steffen R. Epidemiology of traveler’s diarrhea. Clin Infect Dis 2005; 41: S536-40
75. Kendall ME, Crim S, Fullerton K, Han PV, Cronquist AB, Shiferaw B, et al. Travel-associated enteric infections diagnosed after return to the United States, Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2009. Clin Infect Dis 2012; 54: S480-7
76. Sivapalasingam S, Nelson JM, Joyce K, Hoekstra M, Angulo FJ, Mintz ED. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob Agents Chemother 2006; 50: 49-54
77. Dutta D, Bhattacharya MK, Dutta S, Datta A, Sarkar D, Bhandari B, et al. Emergence of multidrug-resistant Shigella dysenteriae type 1 causing sporadic outbreak in and around Kolkata, India. J Health Popul Nutr 2003; 21: 79-80
78. Ross S, Controni G, Khan W. Resistance of shigellae to ampicillin and other antibiotics. Its clinical and epidemiological implications. JAMA 1972; 221: 45-7
79. Bhattacharya SK, Datta P, Datta D, Bhattacharya MK, Sen D, Saha MR, et al. Relative efficacy of trimethoprim-sulfamethoxazole and nalidixic acid for acute invasive diarrhea. Antimicrob Agents Chemother 1987; 31: 837
80. Datta P, Sen D. Outbreak of dysentery due to nalidixic acid resistant S. dysenteriae 1 at Agartala, Tripura: a hospital based study. Indian J Public Health 1990; 34: 11-4
81. Chunder N, Bhattacharya SK, Biswas D, Niyogi SK, Kumar R. Isolation of a fluoroquinolone resistant Shigella dysenteriae 1 strain from Calcutta. Indian J Med Res 1997; 106: 494-6
82. Niyogi SK. Increasing antimicrobial resistance-an emerging problem in the treatment of shigellosis. Clin Microbiol Infect 2007; 13: 1141-3
83. Taneja N, Kumar A, Appannanavar S, Verma G, Sharma M. Plasmid-mediated quinolone resistance in Shigella isolates over a decade in India. J Glob Antimicrob Resist 2014; 2: 59-60
84. Niyogi SK, Sarkar K, Lalmalsawma P, Pallai N, Bhattacharya SK. An outbreak of bacillary dysentery caused by quinolone-resistant Shigella dysenteriae type 1 in a northeastern state of India. J Health Popul Nutr 2004; 22: 97
85. World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. Available from: http://whqlibdoc.who.int/publications/2005/9241592330.pdf, accessed on December 10, 2013
86. Arai Y, Nakano T, Katayama Y, Aoki H, Hirayama T, Ooi Y, et al. Epidemiological evidence of multidrug-resistant Shigella sonnei colonization in India by sentinel surveillance in a Japanese quarantine station. Kansenshogaku Zasshi 2008; 82: 322-7
87. Ghosh S, Pazhani GP, Niyogi SK, Nataro JP, Ramamurthy T. Genetic characterization of Shigella spp. isolated from diarrhoeal and asymptomatic children. J Med Microbiol 2014; 63: 903-10
88. Ke X, Gu B, Pan S, Tong M. Epidemiology and molecular mechanism of integron-mediated antibiotic resistance in Shigella. Arch Microbiol 2011; 193: 767-74
89. Jacoby GA, Gacharna N, Black TA, Miller GH, Hooper DC. Temporal appearance of plasmid-mediated quinolone resistance genes. Antimicrob Agents Chemother 2009; 53: 1665-6
90. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, et al. Fluoroquinolone-modifying 127 enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 2006; 12: 83-8
91. Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, Hooper DC. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 2009; 53: 639-45
92. Pu XY, Pan JC, Wang HQ, Zhang W, Huang ZC, Gu YM. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. J Antimicrob Chemother 2009; 63: 917-20
93. Bhattacharya D, Bhattacharjee H, Thamizhmani R, Sayi DS, Bharadwaj AP, Singhania M, et al. Prevalence of the plasmid-mediated quinolone resistance determinants among clinical isolates of Shigella sp. in Andaman & Nicobar Islands, India. Lett Appl Microbiol 2011; 53: 247-51
94. Pfaller MA, Segreti J. Overview of epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Clin Infect Dis 2006; 42: S153-63
95. Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Hsueh PR, Paterson DL. Emergence of high levels of extended-spectrum-beta-lactamase-producing Gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother 2009; 53: 3280-4
96. Ensor VM, Shahid M, Evans JT, Hawkey PM. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 2006; 58: 1260-3
97. Levine MM, Kotloff KL, Barry EM, Pasetti MF, Sztein MB. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol 2007; 5: 540-53
98. Turbyfill KR, Kaminski RW, Oaks EV. Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a. Vaccine 2008; 26: 1353-64
99. Mukhopadhaya A, Mahalanabis D, Chakrabarti MK. Role of Shigella flexneri 2a 34 kDa outer membrane protein in induction of protective immune response. Vaccine 2006; 24: 6028-36
100. Barnoy S, Jeong KI, Helm RF, Suvarnapunya AE, Ranallo RT, Tzipori S, et al. Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity. Vaccine 2010; 28: 1642-54
101. Kotloff KL, Noriega FR, Samandari T, Sztein MB, Losonsky GA, Nataro JP, et al. Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans. Infect Immun 2000; 68: 1034-9
102. Levine MM, Noriega F. A review of the current status of enteric vaccines. P N G Med J 1995; 38: 325-31.